Epstein-Barr Virus New Trends
Epstein-Barr virus (EBV) is a fascinating microorganism, as a "double-facetted" viral agent. After primary infection, it can persist throughout a person's lifetime in a latent form, from which it can reactivate following specific stimuli (i.e., immunodepression). Unlike other herpesvi...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Electronic Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2021
|
| Series: | Infectious Diseases
11 |
| Subjects: | |
| Online Access: | DOAB: download the publication DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000naaaa2200000uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_131080 | ||
| 005 | 20231201 | ||
| 003 | oapen | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 20231201s2021 xx |||||o ||| 0|eng d | ||
| 020 | |a intechopen.87415 | ||
| 020 | |a 9781839684906 | ||
| 020 | |a 9781839684890 | ||
| 020 | |a 9781839684913 | ||
| 040 | |a oapen |c oapen | ||
| 024 | 7 | |a 10.5772/intechopen.87415 |c doi | |
| 041 | 0 | |a eng | |
| 042 | |a dc | ||
| 072 | 7 | |a MJCJ |2 bicssc | |
| 100 | 1 | |a Drouet, Emmanuel |4 edt | |
| 700 | 1 | |a Drouet, Emmanuel |4 oth | |
| 245 | 1 | 0 | |a Epstein-Barr Virus |b New Trends |
| 260 | |b IntechOpen |c 2021 | ||
| 300 | |a 1 electronic resource (128 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Infectious Diseases |v 11 | |
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a Epstein-Barr virus (EBV) is a fascinating microorganism, as a "double-facetted" viral agent. After primary infection, it can persist throughout a person's lifetime in a latent form, from which it can reactivate following specific stimuli (i.e., immunodepression). Unlike other herpesviruses, EBV reactivates a countless number of times with such a high replication rate that it is unable to be controlled by conventional anti-herpesvirus drugs. Moreover, for various reasons, no vaccine is currently available in the market. This book presents a comprehensive overview of EBV, including information on its potential for oncogenic activity, its various isolates, and possible vaccine candidates. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/3.0/ |2 cc |4 https://creativecommons.org/licenses/by/3.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Infectious & contagious diseases |2 bicssc | |
| 653 | |a immunotherapy, vaccine, innate immunity, autoimmunity, mutation, carcinogenesis | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mts.intechopen.com/storage/books/9619/authors_book/authors_book.pdf |7 0 |z DOAB: download the publication |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/131080 |7 0 |z DOAB: description of the publication |